4//SEC Filing
Tattoli Mark Damian 4
Accession 0001193125-26-002257
CIK 0001958086other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 3:18 PM ET
Size
9.8 KB
Accession
0001193125-26-002257
Insider Transaction Report
Form 4
Tattoli Mark Damian
SVP, Gen Counsel & Secretary
Transactions
- Tax Payment
Common Stock
2025-12-31$16.03/sh−14,310$229,389→ 27,360.621 total - Exercise/Conversion
Common Stock
2025-12-31+24,952→ 41,670.621 total - Exercise/Conversion
Performance Shares
2025-12-31−24,952→ 0 totalExercise: $0.00→ Common Stock (24,952 underlying)
Holdings
- 20(indirect: Custodial account)
Common Stock
- 1,694.842(indirect: 401 (k) Plan)
Common Stock
Footnotes (1)
- [F1]These shares were awarded as restricted performance shares in February 2023, as disclosed in the Reporting Person's Form 4 filing on February 21, 2023. The Company finished in the 68th percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2025. Therefore, the performance criteria and requirements for vesting have been satisfied at 116.5% of the target award level, and such number of shares vested on December 31, 2025.
Documents
Issuer
Core Laboratories Inc. /DE/
CIK 0001958086
Entity typeother
Related Parties
1- filerCIK 0001872069
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 3:18 PM ET
- Size
- 9.8 KB